Chronic Obstructive Pulmonary Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chronic Obstructive Pulmonary Disease stocks.

Chronic Obstructive Pulmonary Disease Stocks Recent News

Date Stock Title
Apr 27 AZN AstraZeneca: A Triple Shot Of Income, Growth, And Value
Apr 27 AZN AstraZeneca PLC (LON:AZN) Beat Earnings, And Analysts Have Been Reviewing Their Forecasts
Apr 26 AZN Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Apr 26 AZN AstraZeneca: Strong In A Weak Market
Apr 26 GTLS Chart Industries (GTLS) Reports Next Week: Wall Street Expects Earnings Growth
Apr 26 AZN Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Apr 26 AZN Top 4 Health Care Stocks That May Plunge This Month
Apr 26 APLS Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)
Apr 26 GTLS Here's How You Should Play 3M Stock Ahead of Q1 Earnings
Apr 25 AZN AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
Apr 25 AZN Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Apr 25 AZN AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Apr 25 GTLS Here's How You Should Play 3M (MMM) Stock Ahead of Q1 Earnings
Apr 25 GTLS 5 Industrial Products Stocks to Buy on Jump in Durable Goods Orders
Apr 25 AZN Top Midday Stories: Shares of Meta, IBM, Caterpillar, Comcast and Southwest Down Big Post-Earnings; AstraZeneca Shares See Post-Earnings Bump
Apr 25 AZN AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
Apr 25 AZN AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript
Apr 25 AZN AstraZeneca reinforcing supply chain amid global tensions: CEO
Apr 25 AZN 20 Fastest Growing Health Tech Companies in the World
Apr 25 AZN Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult. Chronic bronchitis and emphysema are older terms used for different types of COPD. The term "chronic bronchitis" is still used to define a productive cough that is present for at least three months each year for two years.Tobacco smoking is the most common cause of COPD, with factors such as air pollution and genetics playing a smaller role. In the developing world, one of the common sources of air pollution is poorly vented heating and cooking fires. Long-term exposure to these irritants causes an inflammatory response in the lungs, resulting in narrowing of the small airways and breakdown of lung tissue. The diagnosis is based on poor airflow as measured by lung function tests. In contrast to asthma, the airflow reduction does not improve much with the use of a bronchodilator.Most cases of COPD can be prevented by reducing exposure to risk factors. This includes decreasing rates of smoking and improving indoor and outdoor air quality. While treatment can slow worsening, no cure is known. COPD treatments include smoking cessation, vaccinations, respiratory rehabilitation, and often inhaled bronchodilators and steroids. Some people may benefit from long-term oxygen therapy or lung transplantation. In those who have periods of acute worsening, increased use of medications and hospitalization may be needed.As of 2015, COPD affected about 174.5 million (2.4%) of the global population. It typically occurs in people over the age of 40. Males and females are affected equally commonly. In 2015, it resulted in 3.2 million deaths, up from 2.4 million deaths in 1990. More than 90% of these deaths occur in the developing world. The number of deaths is projected to increase further because of higher smoking rates in the developing world, and an aging population in many countries. It resulted in an estimated economic cost of $2.1 trillion in 2010.

Browse All Tags